Skip to content
DraconiticResearch
Search Sources API
201,683 studies31 sourcesUpdated 56 min ago
Peer-reviewedCC BY-NC-NDBMC pediatrics

Initial response and long-term prognostic risk factors in pediatric ITP.

  1. 1Department of Hematology and Oncology of Children's Hospital of Chongqing Medical University, National Clinical Research Center for Children and Adolescents' Health and Diseases, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatric Metabolism and Inflammatory Diseases, No.136 of Zhongshan 2 road, Yu Zhong district, Chongqing, 400014, China.
  2. 2Department of physical examination center, The Second People's Hospital of Liangshan Yi Autonomous Prefecture, Xichang, Sichuan province, 615000, China.

Abstract

Objective

To explore the clinical features and prognostic factors for initial response and long-term prognosis of pediatric immune thrombocytopenia (ITP).Method

A retrospective cohort study of 910 cases of pediatric patients with ITP was conducted. Demographic data, platelet counts, triggers, bleeding grades, glucocorticoid (GC) tapering time, IVIG status and treatment outcomes were collected. Initial response was defined as a platelet counts ≥ 30 × 10⁹/L and at least doubling baseline at 1 month after first-line therapy. Logistic regression analysis and restricted cubic spline (RCS) analyses were performed to identify the risk factors for initial response and long-term prognosis.Results

GC tapering time (OR = 0.39, 95% CI:0.16-0.91, p = 0.03) and bleeding grade 5 (OR = 0.26, 95% CI:0.11-0.52, p < 0.001) were significantly associated with initial response. Age ≥ 3 years (OR = 1.83, 95% CI: 1.18-2.84, p = 0.007) was identified as an independent risk factor for long-term prognosis of pediatric ITP. RCS analysis revealed a nonlinear association between age and the progression of persistent and chronic ITP (p = 0.0012), with two inflection points at approximately 3.75 and 8 years. The risk of progression increased rapidly before 3.75 years, stabilized between 3.75 and 8 years, and rose sharply thereafter, indicating that age ≥ 8 years was at particularly high risk. Neither IVIG administration (OR = 0.99, 95% CI: 0.65-1.53, p = 0.98) nor GC tapering time ≥ 7 days (OR = 1.62, 95% CI: 0.76-3.43, p = 0.21) was significantly associated with long-term prognosis.Conclusion

Age was an independent risk factor for progression to persistent and chronic ITP. Short-course GC regimens could be a rational therapeutic alternative for pediatric ITP patients without severe manifestations or life-threatening bleeding, and age-stratified risk management merits clinical consideration.

Related

  1. Prognostic value of OCT biomarkers and systemic factors for early and long term anatomical treatment response in diabetic macular edema
    Tuğçe Özdemir, Gürkan Erdoğan, Zafer Cebeci
    BMC OphthalmologyPeer-reviewedCC BY 4.0Full textGeneral medicinePMC
  2. Clinical characteristics, long-term outcomes, and prognostic factors in linear IgA bullous dermatosis: A retrospective cohort study across the age spectrum in China, 2008-2025.
    Zhe Wang, Zhenzhen Wang, Wenchao Li +9
    JAAD internationalPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Clinical outcomes and prognostic factors in pediatric acute myeloid leukemia with monocytic differentiation: a single-center cohort study from Egypt
    Tarek Ahmed Abdelrehim Ahmed, Mahmoud Hammad, Sonya Soliman +4
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyPMCCrossrefEurope PMC
  4. Diagnostic delay as a prognostic factor for non-response to treatment and relapse in Mexican pediatric patients with central nervous system tumors
    Juan-Carlos Pérez-De Marcos, Manuel Castillejos-López, Arnoldo Aquino-Gálvez +6
    Frontiers in pediatricsPeer-reviewedCC BYFull textHuman geneticsEurope PMCPMC
  5. Long-term outcomes and prognostic factors in patients aged 70 years or older with early esophageal squamous cell carcinoma undergoing endoscopic submucosal dissection
    Jian-bo Li, Wei Wei, Shuo Guo +2
    Langenbeck's Archives of SurgeryPeer-reviewedCC BY-NC-ND 4.0Full textSurgery & anaesthesiaPMC
BibTeX
@article{zhang2026initial,
  title = {{Initial response and long-term prognostic risk factors in pediatric ITP.}},
  author = {Li Zhang and Jiebin Qin and Lan Huang and Xianhao Wen and Haiyan Liu and Yuxia Guo and Xingtian Xuan and Chunmei Xu and Li Xiao and Jie Yu},
  journal = {BMC pediatrics},
  year = {2026},
  month = sep,
  doi = {10.1186/s12887-026-07572-1},
  url = {https://europepmc.org/article/MED/42907786},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Initial response and long-term prognostic risk factors in pediatric ITP.
AU  - Li Zhang
AU  - Jiebin Qin
AU  - Lan Huang
AU  - Xianhao Wen
AU  - Haiyan Liu
AU  - Yuxia Guo
AU  - Xingtian Xuan
AU  - Chunmei Xu
AU  - Li Xiao
AU  - Jie Yu
PY  - 2026
DA  - 2026/09/01
JO  - BMC pediatrics
DO  - 10.1186/s12887-026-07572-1
UR  - https://europepmc.org/article/MED/42907786
AB  - Objective  To explore the clinical features and prognostic factors for initial response and long-term prognosis of pediatric immune thrombocytopenia (ITP).Method  A retrospective cohort study of 910 cases of pediatric patients with ITP was conducted. Demographic data, platelet counts, triggers, bleeding grades, glucocorticoid (GC) tapering time, IVIG status and treatment outcomes were collected. Initial response was defined as a platelet counts ≥ 30 × 10⁹/L and at least doubling baseline at 1 month after first-line therapy. Logistic regression analysis and restricted cubic spline (RCS) analyses were performed to identify the risk factors for initial response and long-term prognosis.Results  GC tapering time (OR = 0.39, 95% CI:0.16-0.91, p = 0.03) and bleeding grade 5 (OR = 0.26, 95% CI:0.11-0.52, p < 0.001) were significantly associated with initial response. Age ≥ 3 years (OR = 1.83, 95% CI: 1.18-2.84, p = 0.007) was identified as an independent risk factor for long-term prognosis of pediatric ITP. RCS analysis revealed a nonlinear association between age and the progression of persistent and chronic ITP (p = 0.0012), with two inflection points at approximately 3.75 and 8 years. The risk of progression increased rapidly before 3.75 years, stabilized between 3.75 and 8 years, and rose sharply thereafter, indicating that age ≥ 8 years was at particularly high risk. Neither IVIG administration (OR = 0.99, 95% CI: 0.65-1.53, p = 0.98) nor GC tapering time ≥ 7 days (OR = 1.62, 95% CI: 0.76-3.43, p = 0.21) was significantly associated with long-term prognosis.Conclusion  Age was an independent risk factor for progression to persistent and chronic ITP. Short-course GC regimens could be a rational therapeutic alternative for pediatric ITP patients without severe manifestations or life-threatening bleeding, and age-stratified risk management merits clinical consideration.
SN  - 1471-2431
ER  -